140 related articles for article (PubMed ID: 31284860)
1. The Therapeutic Potential of Small Activating RNAs for Colorectal Carcinoma.
Zheng B; Mai Q; Jiang J; Zhou Q
Curr Gene Ther; 2019; 19(3):140-146. PubMed ID: 31284860
[TBL] [Abstract][Full Text] [Related]
2. Specific up-regulation of p21 by a small active RNA sequence suppresses human colorectal cancer growth.
Wang LL; Guo HH; Zhan Y; Feng CL; Huang S; Han YX; Zheng WS; Jiang JD
Oncotarget; 2017 Apr; 8(15):25055-25065. PubMed ID: 28445988
[TBL] [Abstract][Full Text] [Related]
3. Development of MTL-CEBPA: Small Activating RNA Drug for Hepatocellular Carcinoma.
Setten RL; Lightfoot HL; Habib NA; Rossi JJ
Curr Pharm Biotechnol; 2018; 19(8):611-621. PubMed ID: 29886828
[TBL] [Abstract][Full Text] [Related]
4. saRNAdb: Resource of Small Activating RNAs for Up-regulating the Gene Expression.
Dar SA; Kumar M
J Mol Biol; 2018 Jul; 430(15):2212-2218. PubMed ID: 29625201
[TBL] [Abstract][Full Text] [Related]
5. Small non-coding RNA and colorectal cancer.
Chen H; Xu Z; Liu D
J Cell Mol Med; 2019 May; 23(5):3050-3057. PubMed ID: 30801950
[TBL] [Abstract][Full Text] [Related]
6. [Small non-coding RNA and RNA activation].
Pan SL; Yu YY
Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):280-2. PubMed ID: 23928543
[No Abstract] [Full Text] [Related]
7. Activation of KLF4 expression by small activating RNA promotes migration and invasion in colorectal epithelial cells.
Zhou Q; Fan D; Huang K; Chen X; Chen Y; Mai Q
Cell Biol Int; 2018 Apr; 42(4):495-503. PubMed ID: 29274293
[TBL] [Abstract][Full Text] [Related]
8. Current Advances in Small Activating RNAs for Gene Therapy: Principles, Applications and Challenges.
Zhou LY; He ZY; Xu T; Wei YQ
Curr Gene Ther; 2018; 18(3):134-142. PubMed ID: 29921205
[TBL] [Abstract][Full Text] [Related]
9. Development and Mechanism of Small Activating RNA Targeting CEBPA, a Novel Therapeutic in Clinical Trials for Liver Cancer.
Voutila J; Reebye V; Roberts TC; Protopapa P; Andrikakou P; Blakey DC; Habib R; Huber H; Saetrom P; Rossi JJ; Habib NA
Mol Ther; 2017 Dec; 25(12):2705-2714. PubMed ID: 28882451
[TBL] [Abstract][Full Text] [Related]
10. Small Activating RNAs: Towards the Development of New Therapeutic Agents and Clinical Treatments.
Ghanbarian H; Aghamiri S; Eftekhary M; Wagner N; Wagner KD
Cells; 2021 Mar; 10(3):. PubMed ID: 33800164
[TBL] [Abstract][Full Text] [Related]
11. Small activating RNA binds to the genomic target site in a seed-region-dependent manner.
Meng X; Jiang Q; Chang N; Wang X; Liu C; Xiong J; Cao H; Liang Z
Nucleic Acids Res; 2016 Mar; 44(5):2274-82. PubMed ID: 26873922
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms involved in the activation of C/EBPα by small activating RNA in hepatocellular carcinoma.
Zhao X; Reebye V; Hitchen P; Fan J; Jiang H; Sætrom P; Rossi J; Habib NA; Huang KW
Oncogene; 2019 May; 38(18):3446-3457. PubMed ID: 30643190
[TBL] [Abstract][Full Text] [Related]
13. Targeted induction of endogenous NKX3-1 by small activating RNA inhibits prostate tumor growth.
Ren S; Kang MR; Wang J; Huang V; Place RF; Sun Y; Li LC
Prostate; 2013 Oct; 73(14):1591-601. PubMed ID: 23836514
[TBL] [Abstract][Full Text] [Related]
14. Promoter-Targeted Small Activating RNAs Alter Nucleosome Positioning.
Wang B; Hu Y
Adv Exp Med Biol; 2017; 983():53-61. PubMed ID: 28639191
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Potential of Small Activating RNAs (saRNAs) in Human Cancers.
Yoon S; Rossi JJ
Curr Pharm Biotechnol; 2018; 19(8):604-610. PubMed ID: 29804529
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional regulation of E-cadherin by small activating RNA: A new double-stranded RNA.
Wu Z; Li Y; Li Z; Liu Z; Qin Z; Li X; Ye Y; Bu L; Lin B; Wang Z; Jia G; Chen G
Int J Oncol; 2016 Oct; 49(4):1620-8. PubMed ID: 27498620
[TBL] [Abstract][Full Text] [Related]
17. Tumor-selective lipopolyplex encapsulated small active RNA hampers colorectal cancer growth in vitro and in orthotopic murine.
Wang LL; Feng CL; Zheng WS; Huang S; Zhang WX; Wu HN; Zhan Y; Han YX; Wu S; Jiang JD
Biomaterials; 2017 Oct; 141():13-28. PubMed ID: 28666099
[TBL] [Abstract][Full Text] [Related]
18. Nuclear lncRNA HOXD-AS1 suppresses colorectal carcinoma growth and metastasis via inhibiting HOXD3-induced integrin β3 transcriptional activating and MAPK/AKT signalling.
Yang MH; Zhao L; Wang L; Ou-Yang W; Hu SS; Li WL; Ai ML; Wang YQ; Han Y; Li TT; Ding YQ; Wang S
Mol Cancer; 2019 Mar; 18(1):31. PubMed ID: 30823921
[TBL] [Abstract][Full Text] [Related]
19. RNAi technology: a revolutionary tool for the colorectal cancer therapeutics.
Lv W; Zhang C; Hao J
World J Gastroenterol; 2006 Aug; 12(29):4636-9. PubMed ID: 16937431
[TBL] [Abstract][Full Text] [Related]
20. RNA-mediated gene activation.
Jiao AL; Slack FJ
Epigenetics; 2014 Jan; 9(1):27-36. PubMed ID: 24185374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
